Page 26 - Avoid Food and Drug Interactions

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved. References List

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved. • Marek PE. Death by total parenteral nutrition. The saga continues. Crit Care Med 2011;39:1536-1537.
• Lipman TO. Grains vs veins: is enteral nutrition really better that parenteral nutrition? A look at the evidence. JPEN J Parenteral and

Enteral Nutrition 1995:22:167-182.
• Jeejeebhoy KN. Total parenteral nutrition – potion or poison. Am J Clin Nutr 2001;74:160-163.
• Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future

research directions. A summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and
Enteral Nutrition and American Society for Clinical Nutrition. JPEN J Parenteral and Enteral Nutrition 1997:21:133-156.
• August DA, Huhmann MB. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors, A.S.P.E.N. clinical
guidelines: nutrition support therapy during adult cancer treatment and in hematopoietic cell transplantation. JPEN J Parenteral and
Enteral Nutrition 2009;33:472-500.
• McClave SA, Martindale RG, Vanek VW, et al. Guideline for the provision and assessment of nutrition support therapy in the adult
critically ill patient. Society for Critical Care Medicine (S.C.C.M.) and The American Society for Parenteral and Enteral Nutrition
(A.S.P.E.N.) JPEN J Parenteral and Enteral Nutrition 2009;33:277-316.
• Klek S, Sierzega M, Szykinski P, et al. Perioperative nutrition in malnourished surgical cancer patients-a prospective, randomized,
controlled clinical trial. Clin Nutr 30;708-713, 2011
• Pelzer U, Arnold D, Govercin M, et al. Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC
Cancer 2010;10:86-90.
• Chermish I, Mashiach T, Annil A, et al. Home parenteral nutrition (HTPN) for incurable patients with cancer with gastrointestinal
obstruction. Do the benefits outweigh the risks? Med Oncol 2011;28:83-88.
• Pironi C, Avend A, Baxter J, et al. ESPEN endorsed recommendations: definition and classification of intestinal failure in adults, Clin
Nutr 2015;34:171-180.

47

References List

• Worthington P, Balint J, Bechtold M, et al. When is parenteral nutrition appropriate? JPEN J Parenteral and
Enteral Nutrition 2017;41:324-377.

• ASPEN. Appropriate Dosing for Parenteral Nutrition. ASPEN Recommendations. January 2019.
http://www.nutritioncare.org/PNDosing

• Mirtallo JM, et al. A.S.P.E.N. Safe Practices for Parenteral Nutrition. JPEN J Parenteral and Enteral Nutrition
2004;28(6):S39-S70.

• Cheung NW, Zaccaria C, Napier B, Fletcher JP. Hyperglycemia is associated with adverse outcomes in
patients receiving total parenteral nutrition. Diabetes Care 28:2367-2371, 2005.

• Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total
parenteral nutrition. Nutr Clin Pract 11:151-156, 1996.

• Pleva M, Mirtallo JM, Steinberg SM. Hyperglycemic events in non-intensive care unit patients receiving
parenteral nutrition. Nutr Clin Pract 24: 626-634, 2009.

• Russell MK, Wischmeyer PV. Supplemental parenteral nutrition: review of the literature and current nutrition
guidelines. Nutr Clin Pract 2018;33:359-369.

• Oshima T, Heidegger C-P, Pichard C. Supplemental parenteral nutrition is the key to prevent energy deficits in
critically ill patients. Nutr Clin Pract 2016;31:432-437.

48

26